| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402537 | Journal of Surgical Research | 2005 | 6 Pages |
Abstract
Patients with an elevated level of both CEA and CA19-9 in stage II of colorectal cancer have a significantly poorer prognosis than those with normal levels of these markers. We recommend adding both CEA and CA19-9 to the current staging system.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Chien-Chih M.D., Shung-Haur M.D., Jen-Kou M.D., Ph.D., Tzu-Chen M.D., Wei-Shone M.D., Ph.D., Jeng-Kae M.D., Ph.D., Huann-Sheng M.D., Shih-Ching M.D.,